Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma.

Felipe de Galiza BarbosaOliver RiestererStephanie Tanadini-LangSonja StiebGabriela StuderMartin PruschyGerhard F HuberMartin W HuellnerPaul StolzmannPatrick Veit-Haibach

Published in: Head & neck (2019)

Clinical Trials.gov identifier: NCT01435252.

Keyphrases

locally advanced
squamous cell carcinoma
clinical trial
rectal cancer
high resolution
radiation therapy
optic nerve
lymph node metastasis
metastatic colorectal cancer
phase ii
randomized controlled trial
mass spectrometry